Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.

Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B; HIV Neuroimaging Consortium..

AIDS. 2011 Mar 13;25(5):625-33. doi: 10.1097/QAD.0b013e3283427da7.

2.

Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap.

McArthur JC, Steiner J, Sacktor N, Nath A.

Ann Neurol. 2010 Jun;67(6):699-714. doi: 10.1002/ana.22053. Review.

PMID:
20517932
3.

Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.

Gras G, Kaul M.

Retrovirology. 2010 Apr 7;7:30. doi: 10.1186/1742-4690-7-30. Review.

4.

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.

Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, Pulliam L.

J Neurovirol. 2010 Mar;16(2):115-24. doi: 10.3109/13550280903559789.

PMID:
20307252
5.

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

Clifford DB, Smurzynski M, Park LS, Yeh TM, Zhao Y, Blair L, Arens M, Evans SR.

Neurology. 2009 Jul 28;73(4):309-14. doi: 10.1212/WNL.0b013e3181af7a10.

6.

Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Martin-Thormeyer EM, Paul RH.

Neuropsychol Rev. 2009 Jun;19(2):215-31. doi: 10.1007/s11065-009-9101-6. Epub 2009 May 27. Review.

7.

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, Prats A, Negredo E, Garolera M, Pérez-Alvarez N, Moltó J, Gómez G, Clotet B.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1301-7. doi: 10.1089/aid.2007.0310.

PMID:
18844464
8.

Neurocognition in individuals co-infected with HIV and hepatitis C.

Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ.

J Addict Dis. 2008;27(2):11-7. doi: 10.1300/J069v27n02_02.

9.
10.

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D.

PLoS One. 2008 Jun 25;3(6):e2516. doi: 10.1371/journal.pone.0002516.

11.

Biomarkers of HIV related central nervous system disease.

Brew BJ, Letendre SL.

Int Rev Psychiatry. 2008 Feb;20(1):73-88. doi: 10.1080/09540260701878082. Review.

PMID:
18240064
12.

Neurocognitive disturbances in HIV.

Grant I.

Int Rev Psychiatry. 2008 Feb;20(1):33-47. doi: 10.1080/09540260701877894. Review.

PMID:
18240061
13.

The Neuropathology of HIV/AIDS.

Anthony IC, Bell JE.

Int Rev Psychiatry. 2008 Feb;20(1):15-24. doi: 10.1080/09540260701862037. Review.

PMID:
18240059
14.

Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Bell JE, Arango JC, Anthony IC.

J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91. Epub 2006 May 5. Review.

PMID:
18040783
15.

Updated research nosology for HIV-associated neurocognitive disorders.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.

16.

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K; CASCADE Collaboration..

Ann Neurol. 2008 Feb;63(2):213-21.

PMID:
17894380
17.

Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.

Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E; HIV Neurobehavioral Research Center Group..

J Infect Dis. 2007 Aug 1;196(3):361-70. Epub 2007 Jun 15.

PMID:
17597450
18.

Associative and predictive biomarkers of dementia in HIV-1-infected patients.

Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ.

Neurology. 2007 May 1;68(18):1481-7.

19.

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.

Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG.

Arch Neurol. 2007 Jan;64(1):97-102.

PMID:
17210815
20.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC.

Nat Med. 2006 Dec;12(12):1365-71. Epub 2006 Nov 19.

PMID:
17115046

Supplemental Content

Support Center